“We will evaluate how the commercialization of the substance fits in with our small business product at Adastra in an effort to place ourselves to assist the demand for a safe offer of copyright,” claimed Main executive officer Michael Forbes in a very information release. The business told VICE Information it would not be commenting more.Deale